CD38 and neoplasm: While this possibility needs to be tested in appropriate in vivo models, in this study we provide early ex vivo evidence, supporting this possibility by demonstrating that CD38-CAR iNKT cells which were continuously stimulated with tumor cells can still be expanded by simulation with α-GalCer loaded DCs.